Long-term patterns of in-breast failure in patients with early stage breast cancer treated with breast-conserving therapy: A molecular based clonality evaluation

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 33, Issue 1, 2010, Pages 17-22

  McGrath, Samuel ^a   Antonucci, John ^a   Goldstein, Neal ^a   Wallace, Michelle ^a   Mitchell, Chris ^a   Grills, Inga ^a   Jolly, Shruti ^b   Kestin, Larry ^a   Vicini, Frank ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Allelic imbalance; Breast conserving therapy; Local recurrence; Loss of heterozygosity; Radiation therapy

Indexed keywords

TAMOXIFEN;

ADULT; ALLELE; ALLELIC IMBALANCE; ARTICLE; BRACHYTHERAPY; BREAST CANCER; BREAST CARCINOMA; BREAST METASTASIS; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; MOLECULAR CLONING; POLYMERASE CHAIN REACTION; SYSTEMIC THERAPY; TREATMENT FAILURE;

BREAST NEOPLASMS; CLONE CELLS; DIAGNOSIS, DIFFERENTIAL; DNA, NEOPLASM; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; LYMPHATIC METASTASIS; MICROSATELLITE REPEATS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 76749132087     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e31819cccc3     Document Type: Article

References (40)

1. Haffty BG, Reiss M, Beinfield M, et al. Ipsilateral breast tumor recurrence as a predictor of distant disease: implications for systemic therapy at the time of local relapse. J Clin Oncol. 1996;14:52-57.
2. Recht A, Silen W, Schnitt SJ, et al. Time-course of local recurrence following conservative surgery and radiotherapy for early stage breast cancer. Int J Radiat Oncol Biol Phys. 1988;15:255-261.
3. Sidransky D. Nucleic acid-based methods for the detection of cancer. Science. 1997;278:1054-1059.
4. Lasko D, Cavenee W, Nordenskjold M. Loss of constitutional heterozygosity in human cancer. Ann Rev Genet. 1991;25:281-314.
5. Bianchi AB, Navone NM, Conti CJ. Detection of loss of heterozygosity in formalin-fixed paraffin-embedded tumor specimens by the polymerase chain reaction. Am J Pathol. 1991;138:279-284.
6. Wang Y, Hung SC, Linn JF, et al. Microsatellite-based cancer detection using capillary array electrophoresis and energy-transfer fluorescent primers. Electrophoresis. 1997;18:1742-1749. (Pubitemid 27451828)
7. Mead LJ, Gillespie MT, Hung JY, et al. Frequent loss of heterozygosity in early non-small-cell lung cancers at chromosome 9p21 proximal to the CDKN2a gene. Int J Cancer. 1997;71:213-217.
8. Leong PP, Rezai B, Koch WM, et al. Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma. J Natl Cancer Inst. 1998;90:972-977.
9. Kollias J, Man S, Marafie M, et al. Loss of heterozygosity in bilateral breast cancer. Breast Cancer Res Treat. 2000;64:241-251.
10. Kung FY, Tse GM, Lo KW, et al. Metachronous bilateral mammary metaplastic and infiltrating duct carcinomas: a molecular study for clonality. Hum Pathol. 2002;33:677-679.
11. Lininger RA, Fujii H, Man YG, et al. Comparison of loss heterozygosity in primary and recurrent ductal carcinoma in situ of the breast. Mod Pathol. 1998;11:1151-1159.
12. Regitnig P, Moser R, Thalhammer M, et al. Microsatellite analysis of breast carcinoma and corresponding local recurrences. J Pathol. 2002;198:190-197.
13. Regitnig P, Ploner F, Maderbacher M, et al. Bilateral carcinomas of the breast with local recurrence: analysis of genetic relationship of the tumors. Mod Pathol. 2004;17:597-602.
14. Tse GM, Kung FY, Chan AB, et al. Clonal analysis of bilateral mammary carcinomas by clinical evaluation and partial allelotyping. Am J Clin Pathol. 2003;120:168-174.
15. Schlechter BL, Yang Q, Larson PS, et al. Quantitative DNA fingerprinting may distinguish new primary breast cancer from disease recurrence. J Clin Oncol. 2004;22:1830-1838. (Pubitemid 41095173)
16. Hampl M, Hampl JA, Reiss G, et al. Loss of heterozygosity accumulation in primary breast carcinomas and additionally in corresponding distant metastases is associated with poor outcome. Clin Cancer Res. 1999;5:1417-1425.
17. Vicini FA, Antonucci JV, Goldstein NS, et al. The use of molecular assays to establish definitively the clonality of ipsilateral breast tumor recurrences and patterns of in-breast failure in patients with early-stage breast cancer treated with breast-conserving therapy. Cancer. 2007;109:1264-1272.
18. Vicini FA, Goldstein NS, Pass H, et al. Use of pathologic factors to assist in establishing adequacy of excision before radiotherapy in patients treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2004;60:86-94. (Pubitemid 39165472)
19. Vicini FA, Kestin L, Chen P, et al. Limited-field radiation therapy in the management of early-stage breast cancer. J Natl Cancer Inst. 2003;95:1205-1210.
20. Vicini FA, Beitsch PD, Quiet CA, et al. First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity: results of the American Society of Breast Surgeons MammoSite breast brachytherapy trial. Cancer. 2005;104:1138-1148.
21. Goldstein NS, Vicini FA, Hunter S, et al. Molecular clonality determination of ipsilateral recurrence of invasive breast carcinomas after breast-conserving therapy: comparison with clinical and biologic factors. Am J Clin Pathol. 2005;123:679-689.
22. Goldstein NS, Vicini FA, Hunter S, et al. Molecular clonality relationships in initial carcinomas, ipsilateral breast failures, and distant metastases in patients treated with breast-conserving therapy: evidence suggesting that some distant metastases are derived from ipsilateral breast failures and that metastases can metastasize. Am J Clin Pathol. 2005;124:49-57.
23. Sieben NL, Kolkman-Uljee SM, Flanagan AM, et al. Molecular genetic evidence for monoclonal origin of bilateral ovarian serous borderline tumors. Am J Pathol. 2003;162:1095-1101.
24. Recht A, Silen W, Schnitt SJ, et al. Time-course of local recurrence following conservative surgery and radiotherapy for early stage breast cancer. Int J Radiat Oncol Biol Phys. 1988;15:255-261.
25. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat. 1958;53:457-481.
26. Nakayama T, Taback B, Turner R, et al. Molecular clonality of in-transit melanoma metastasis. Am J Pathol. 2001;158:1371-1378.
27. Sieben NL, Kolkman-Uljee SM, Flanagan AM, et al. Molecular genetic evidence for monoclonal origin of bilateral ovarian serous borderline tumors. Am J Pathol. 2003;162:1095-1101.
28. Huang J, Behrens C, Wistuba I, et al. Molecular analysis of synchronous and metachronous tumors of the lung: impact on management and prognosis. Ann Diagn Pathol. 2001;5:321-329.
29. Altimari A, Gruppioni E, Fiorentino M, et al. Genomic allelotyping for distinction of recurrent and de novo hepatocellular carcinoma after orthotopic liver transplantation. Diagn Mol Pathol. 2005;14:34-38.
30. Hameed O, Pfeifer JD. Classifying "recurrent" breast cancer: lost heterozygosity found. Am J Clin Pathol. 2005;123:641-643.
31. Krauss DJ, Kestin LL, Mitchell C, et al. Changes in temporal patterns of local failure after breast-conserving therapy and their prognostic implications. Int J Radiat Oncol Biol Phys. 2004;60:731-740.
32. Fowble B. Ipsilateral breast tumor recurrence following breast-conserving surgery for early-stage invasive cancer. Acta Oncol. 1999;38(suppl 13):9-17.
33. Doyle T, Schultz DJ, Peters C, et al. Long-term results of local recurrence after breast conservation treatment for invasive breast cancer. Int J Radiat Oncol Biol Phys. 2001;51:74-80.
34. Haffty BG, Fischer D, Beinfield M, et al. Prognosis following local recurrence in the conservatively treated breast cancer patient. Int J Radiat Oncol Biol Phys. 1991;21:293-298.
35. Fowble B, Solin LJ, Schultz DJ, et al. Breast recurrence following conservative surgery and radiation: patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implications for treatment. Int J Radiat Oncol Biol Phys. 1990;19:833-842.
36. DiPaola RS, Orel SG, Fowble BL. Ipsilateral breast tumor recurrence following conservative surgery and radiation therapy. Oncology (Huntingt). 1994;8:59-68.
37. Smith TE, Lee D, Turner BC, et al. True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management. Int J Radiat. Oncol Biol Phys. 2000;48:1281-1289.
38. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a Randomized Trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233-1241.
39. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials. Lancet 2005;366:2087-2106.
40. Huang E, Buchholz TA, Meric F, et al. Classifying local disease recurrences after breast conservation therapy based on location and histology. Cancer. 2002;95:2059-2067.